Rx-3117

RX-3117 · Processa Pharmaceuticals

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Rx-3117, covering 2023-12-06 to 2023-12-06. Get the full timeline:

Most recent: Clinical Trial Update: RX-3117 in Combination With Abraxane® in Subjects With Metastatic Pancreatic Cancer [Phase 1, Phase 2]